{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:49:43Z","timestamp":1761511783681},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s1521-6616(02)00016-5","type":"journal-article","created":{"date-parts":[[2003,2,11]],"date-time":"2003-02-11T17:19:26Z","timestamp":1044983966000},"page":"10-15","source":"Crossref","is-referenced-by-count":14,"title":["Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients"],"prefix":"10.1016","volume":"106","author":[{"given":"Edgar G","family":"Engleman","sequence":"first","affiliation":[]},{"given":"Lawrence","family":"Fong","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1521-6616(02)00016-5_BIB1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.1979.tb00298.x","article-title":"Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation","volume":"48","author":"Lynch","year":"1979","journal-title":"Immunol. Rev."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1749-6632.1993.tb44039.x","article-title":"Clinical trials of idiotype-specific vaccine in B-cell lymphomas","volume":"690","author":"Hsu","year":"1993","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/hyb.1985.4.191","article-title":"Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13","volume":"4","author":"Maloney","year":"1985","journal-title":"Hybridoma"},{"key":"10.1016\/S1521-6616(02)00016-5_BIB4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1084\/jem.164.5.1566","article-title":"Idiotype variant cell populations in patients with B cell lymphoma","volume":"164","author":"Carroll","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB6","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V99.5.1517","article-title":"Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma","volume":"99","author":"Timmerman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S1521-6616(02)00016-5_BIB7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcla.1860050510","article-title":"Carcinoembryonic antigen gene family","volume":"5","author":"Thompson","year":"1991","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB8","first-page":"321","article-title":"Clinical application of carcinoembryonic antigen","volume":"12","author":"Sikorska","year":"1988","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O","article-title":"Carcinoembryonic antigen in breast cancer patients","volume":"33","author":"Steward","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/S1521-6616(02)00016-5_BIB10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-5223(19)40638-7","article-title":"Carcinoembryonic antigen in patients with carcinoma of the lung","volume":"66","author":"Vincent","year":"1978","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1040-8428(85)80008-1","article-title":"CEA-related antigens","volume":"2","author":"Shively","year":"1985","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jnci\/82.5.380","article-title":"Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis","volume":"82","author":"Hostetter","year":"1990","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family","volume":"9","author":"Hammarstrom","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB14","first-page":"12","article-title":"Role of carcinoembryonic antigen in the management of advanced colorectal cancer","volume":"25","author":"Mitchell","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/jnci\/84.14.1084","article-title":"Anti-tumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine","volume":"84","author":"Kantor","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB16","first-page":"676","article-title":"Induction of protective host immunity to carcinoembryonic antigen (CEA), a self antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus","volume":"59","author":"Kass","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB17","first-page":"4570","article-title":"Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen","volume":"57","author":"Zaremba","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<829::AID-IJC16>3.0.CO;2-K","article-title":"Agonist peptide from a cytotoxic T-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide","volume":"85","author":"Salazar","year":"2000","journal-title":"Int. J. Cancer."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood.V91.4.1101","article-title":"c-kit ligand and Flt3 ligand","volume":"91","author":"Lyman","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S1521-6616(02)00016-5_BIB20","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1084\/jem.184.5.1953","article-title":"Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice","volume":"184","author":"Maraskovsky","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/S1521-6616(02)00016-5_BIB22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","article-title":"Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients","volume":"5","author":"Lee","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB23","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.166.6.4254","article-title":"Dendritic cells injected via different routes induce immunity in cancer patients","volume":"166","author":"Fong","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB24","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.4049\/jimmunol.167.12.7150","article-title":"Dendritic cell based xenoantigen vaccination for prostate cancer immunotherapy","volume":"167","author":"Fong","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB26","first-page":"6451","article-title":"Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine","volume":"61","author":"Banchereau","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20012100","article-title":"Rapid Induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells","volume":"195","author":"Schuler-Thurner","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00016-5_BIB28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","article-title":"Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma","volume":"4","author":"Rosenberg","year":"1998","journal-title":"Nat. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661602000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661602000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T02:54:55Z","timestamp":1583981695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661602000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1521661602000165"],"URL":"https:\/\/doi.org\/10.1016\/s1521-6616(02)00016-5","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}